Pr CADIOT Guillaume

Association of bowel urgency, disease activity and disability in patients with inflammatory Bowel Disease: A cross-sectional study from the GETAID.

Amiot A, Ahres A, Stefanescu C, Meyer A, Nachury M, Nancey S, Richard N, Allez M, Altwegg R, Laharie D, Serrero M, Franchimont D, Hupé M, Fumery M, Vuitton L, Nahon S, Gilletta C, Rouillon C, Nuzzo A, Berre CL, Caron B, Buisson A, Amil M, Charkaoui M, Cadiot G, Caillo L, Simon M, Reenaers C, Hébuterne X, Plastaras L, Atanasiu C, Kwiatek S, Uzzan M, Pelletier AL, Benezech A, Vidon M, Goutorbe F, Geyl S, Cellier C, Montuclard C, Moussata D, Seksik P,

Clin Res Hepatol Gastroenterol. 2026 06 5;:102861

ISPAD, bridging clinical expertise and AI for autoimmune-related pernicious anemia diagnosis.

Boumela N, Cadiot G, Chaoui F

Front Immunol. 2026 04 28;17:1700751

Neuroendocrine Tumors and Pregnancy: The French PregNET Study.

Gerard L, Juin C, Perrier M, Cadiot G, Do Cao C, Baudin E, Palmieri LJ, Lombard Bohas C, Walter T, Coriat R

Eur J Endocrinol. 2026 04 11;:

Surgical Management of Zollinger-Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines).

Gaujoux S, Pattou F, Cadiot G, Adham M, Bachellier P, Bail JP, Caiazzo R, Carrere N, Chaffanjon P, Deguelte S, Donatini G, Dousset B, Faron M, Gronnier C, Heyd B, Lifante JC, Lubrano J, Meurisse N, Mirallié E, Santucci N, Sauvanet A, Sebag F, Sulpice L, Thebault B, Tuech JJ, Walter T, Binquet C, Goudet P

World J Surg. 2026 03 20;:

Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network.

Hunaut T, Gérard L, Hercent A, Hentic O, Buecher B, Lepage C, Lecomte T, Thuillier P, Do Cao C, Durand A, Roquin G, Lepere C, Lebras M, Dominguez S, Baltzinger P, Devulder P, Guedj N, Brixi H, Féron T, Cros J, Pasmant E, Lombard-Bohas C, Walter T, Cadiot G, de Mestier L

Endocr Pathol. 2026 03 19;37(1):

Aorto-mesenteric space reduction in women with anorexia nervosa: retrospective audit and analysis.

Taieb L, Meziane Y, Renard Y, Barrois M, Cosse C, Hoeffel C, Cadiot G, Bertin E

J Eat Disord. 2026 03 6;:

Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.

Gendard M, Seksik P, Stefanescu C, Meyer A, Nachury M, Nancey S, Savoye G, Allez M, Laharie D, Serrero M, Franchimont D, Mathieu N, Fumery M, Vuitton L, Nahon S, Gilletta C, Rouillon C, Nuzzo A, Berre CL, Caron B, Buisson A, Amil M, Charkaoui M, Cadiot G, Caillo L, Simon M, Reenaers C, Hébuterne X, Plastaras L, Atanasiu C, Kwiatek S, Uzzan M, Pelletier AL, Benezech A, Vidon M, Goutorbe F, Geyl S, Cellier C, Montuclard C, Moussata D, Altwegg R, Amiot A,

Dig Liver Dis. 2026 02 3;:

Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study.

Fontaine L, Seksik P, Stefanescu C, Nachury M, Nancey S, Savoye G, Allez M, Altwegg R, Laharie D, Serrero M, Franchimont D, Mathieu N, Fumery M, Vuitton L, Nahon S, Gilletta C, Rouillon C, Nuzzo A, Bourreille A, Caron B, Buisson A, Amil M, Charkaoui M, Cadiot G, Caillo L, Simon M, Reenaers C, Hébuterne X, Plastaras L, Atanasiu C, Kwiatek S, Uzzan M, Pelletier AL, Benezech A, Vidon M, Goutorbe F, Geyl S, Cellier C, Montuclard C, Moussata D, Amiot A, Meyer A,

Dig Liver Dis. 2025 12 30;:

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.

Osty M, Altwegg R, Serrero M, Benezech A, Lecomte A, Cadiot G, Vuitton L, Wampach A, Nancey S, Buisson A, le Berre C, Rouillon C, Gilletta C, Goutorbe F, Fumery M, Hammoudi N, Caillo L, Vidon M, Arab N, Sickersen G, Cavicchi M, Vieujean S, Charkaoui M, Richard N, Wils P, Caron B, Amiot A, Nuzzo A, Laharie D, Kirchgesner J, Uzzan M,

Aliment Pharmacol Ther. 2025 05 22;:

PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMission.

Mathieu N, Hupé M, Heluwaert F, Rivière P, Hébuterne X, Chupin A, Abitbol V, Bouguen G, Vuitton L, Gornet JM, Montuclard C, Nancey S, Cadiot G, Wils P, Gilletta C, de Maissin A, Altwegg R, Chanteloup E, Plastaras L, Ah Soune P, Bourreille A, Stefanescu C, Seksik P, Simon M, Uzzan M, Andrau P, Rouillon C, Arondel Y, Buisson A, Peyrin-Biroulet L, Mboup B, Vicaut E, Laharie D

Clin Gastroenterol Hepatol. 2025 05 19;:

Quantitative 177Lu-DOTATATE SPECT/CT is predictive of 6-month PRRT morphological response in midgut neuroendocrine tumors: a pilot study.

Megherbi I, Hoog C, Perrier M, Brixi H, Cadiot G, Hoeffel-Fornes C, Morland D

EJNMMI Res. 2025 05 6;15(1):53

Evaluation of the BIOSECURE Questionnaire in Patients Followed for Inflammatory Rheumatological and Gastrointestinal Diseases Through the Analysis of This Questionnaire.

Beissat M, Geoffroy M, Bolko L, Hittinger A, Bonnet M, Cadiot G, Salmon JH

J Clin Med. 2025 01 22;14(3):

Long-Term Neoplastic Risk Associated With Colorectal Strictures in Crohn's Disease: A Multicenter Study.

Hunaut T, Peyrin-Biroulet L, Le Bozec A, Germain A, Gower-Rousseau C, Sabbagh C, Cadiot G, Fumery M

Gastro Hep Adv. 2024 05 16;3(6):731-737

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.

Mekkan-Bouv Hez M, Derbey L, de Mestier L, D L, Walter T, Perrier M, Cadiot G, Goichot B, Pracht M, Lièvre A, Coriat R, Valancot S, Guimbaud R, Carrere N, Bacoeur-Ouzillou O, Belleannée G, Smith D, Laboureau S, Hescot S, Julie C, Teissier MP, Thereaux J, Ferru A, Evrard C, Mathonnet M, Christou N,

Int J Surg. 2024 04 3;:

Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.

Perrier M, Brugel M, Gérard L, Goichot B, Lièvre A, Lepage C, Hautefeuille V, Do Cao C, Smith D, Thuillier P, Cros J, Cadiot G, Walter T, de Mestier L

Eur J Endocrinol. 2023 12 1;:

Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.

Muller M, Broséus J, Guilloteau A, Wasse S, Thiéblemont C, Nancey S, Cadiot G, Amiot A, Laharie D, Vieujean S, Bouhnik Y, Martineau C, Michiels C, Hebuterne X, Savoye G, Franchimont D, Seksik P, Beaugerie L, Maynadié M, Feugier P, Peyrin-Biroulet L

J Crohns Colitis. 2023 10 18;:

French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d'étude des Tumeurs Endocrines / Association Française de Chirurgie Endocrinienne / REseau NAtional de prise en charge des Tumeurs ENdocrines) for the screening, diagnosis and management of

Goudet P, Cadiot G, Barlier A, Baudin E, Borson-Chazot F, Brunaud L, Caiazzo R, Cardot-Bauters C, Castinetti F, Chanson P, Cuny T, Dansin E, Gaujoux S, Giraud S, Groussin L, Bras ML, Lifante JC, Mathonnet M, de Mestier L, Mirallié E, Pattou F, Romanet P, Sebag F, Tresallet C, Vezzosi D, Walter T, Tabarin A

Ann Endocrinol (Paris). 2023 09 20;:

High Tumor Uptake on F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.

De Rycke O, Perrier M, Ouvrard É, Mennetrey C, Lachachi C, Bando-Delaunay A, Morland D, Goichot B, Taieb D, Walter T, Cadiot G, Cros J, Hentic O, Ruszniewski P, Lebtahi R, Imperiale A, de Mestier L

J Nucl Med. 2023 08 31;:

OPERA: perception of information in patients with GEP-NETs on lanreotide autogel.

Hautefeuille V, Walter T, Do Cao C, Coriat R, Dominguez S, Mineur L, Cadiot G, Terrebonne E, Sobhani I, Gueguen D, Houchard A, Mouawad C, Anota A, Hammel P

Eur J Endocrinol. 2023 08 5;:

Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN study group.

Masson E, Zou WB, Pu N, Rebours V, Génin E, Wu H, Lin JH, Wang YC, ,Abrantes A, Aguilera Munoz L, Albouys J, Alric L, Amiot X, Archambeaud I, Audiau S, Bastide L, Baudon J, Bellaiche G, Bellon S, Bertrand V, Bideau K, Billiemaz K, Billioud C, Bonnefoy S, Borderon C, Bournet B, Breton E, Brugel M, Buscail L, Cadiot G, Camus M, Causse X, Chamouard P, Chaput U, Cholet F, Ciocan DM, Clavel C, Coffin B, Coimet-Berger L, Creveaux I, Culetto A, Daboussi O, Mestier L, Degand T, D'Engremont C, Denis B, Dermine S, Desgrippes R, D'Aubigny AD, Enaud R, Fabre A, Gargot D, Gelsi E, Gentilcore E, Gincul R, Ginglinger-Favre E, Giovannini M, Gomercic C, Gondran H, Grainville T, Grandval P, Grasset D, Grimaldi S, Grimbert S, Hagege H, Heissat S, Hentic O, Herber-Mayne A, Hervouet M, Hoibian S, Jacques J, Jais B, Kaassis M, Koch S, Lacaze E, Lacroute J, Lamireau T, Laurent L, Guillou XL, Rhun ML, Leblanc S, Levy P, Lievre A, Lorenzo D, Maire F, Marcel K, Matias C, Mauillon J, Morgant S, Moussata D, Muller N, Nambot S, Napoleon B, Olivier A, Pagenault M, Pelletier AL, Pennec O, Pinard F, Pioche M, Prost B, Queneherve L, Rebours V, Reboux N, Rekik S, Riachi G, Rohmer B, Roquelaure B, Hezode IR, Rostain F, Saurin JC, Servais L, Stan-Iuga R, Subtil C, Texier C, Thomassin L, Tougeron D, Tsakiris L, Valats JC, Vuitton L, Wallenhorst T, Wangerme M, Zanaldi H, Zerbib F,

Pancreatology. 2023 08;23(5):491-506

Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.

Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot G, Camara M, Christ E, Clerici T, Clift AK, Clouston H, Cobianchi L, Ćwikła JB, Daskalakis K, Frilling A, Garcia-Carbonero R, Grozinsky-Glasberg S, Hernando J, Hervieu V, Hofland J, Holmager P, Inzani F, Jann H, Jimenez-Fonseca P, Kaçmaz E, Kaemmerer D, Kaltsas G, Klimacek B, Knigge U, Kolasińska-Ćwikła A, Kolb W, Kos-Kudła B, Kunze CA, Landolfi S, Rosa S, López CL, Lorenz K, Matter M, Mazal P, Mestre-Alagarda C, Del Burgo PM, van Dijkum EJMN, Oleinikov K, Orci LA, Panzuto F, Pavel M, Perrier M, Reims HM, Rindi G, Rinke A, Rinzivillo M, Sagaert X, Satiroglu I, Selberherr A, Siebenhüner AR, Tesselaar MET, Thalhammer MJ, Thiis-Evensen E, Toumpanakis C, Vandamme T, van den Berg JG, Vanoli A, van Velthuysen MF, Verslype C, Vorburger SA, Lugli A, Ramage J, Zwahlen M, Perren A, Kaderli RM

Lancet Oncol. 2023 01 11;:

FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors.

Lacombe C, Perrier M, Hentic O, Brixi H, De Rycke O, Cros J, Rebours V, Cadiot G, Ruszniewski P, de Mestier L

J Neuroendocrinol. 2022 12 27;:e13227

Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs' uptake on post-treatment quantitative SPECT: A pilot study.

Morland D, Triumbari EKA, Hoog C, Sézin G, Dejust S, Cadiot G, Paris P, Papathanassiou D

Medicine (Baltimore). 2022 12 9;101(49):e32212

The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis.

Masson E, Ewers M, Paliwal S, Kume K, Scotet V, Cooper DN, Rebours V, Buscail L, Rouault K, ,Abrantes A, Aguilera Munoz L, Albouys J, Alric L, Amiot X, Archambeaud I, Audiau S, Bastide L, Baudon J, Bellaiche G, Bellon S, Bertrand V, Bideau K, Billiemaz K, Billioud C, Bonnefoy S, Borderon C, Bournet B, Breton E, Brugel M, Buscail L, Cadiot G, Camus M, Carpentier-Pourquier M, Chamouard P, Chaput U, Chen JM, Cholet F, Ciocan DM, Clavel C, Coffin B, Coimet-Berger L, Cosconea S, Creveaux I, Culetto A, Daboussi O, De Mestier L, Degand T, D'engremont C, Denis B, Dermine S, Desgrippes,Drouet D'Aubigny A, Enaud R, Fabre A, Férec C, Gargot D, Gelsi E, Gentilcore E, Gincul R, Ginglinger-Favre E, Giovannini M, Gomercic C, Gondran H, Grainville T, Grandval P, Grasset D, Grimaldi S, Grimbert S, Hagege H, Heissat S, Hentic O, Herber-Mayne A, Hervouet M, Hoibian S, Jacques J, Jais B, Kaassis M, Koch S, Lacaze E, Lacroute J, Lamireau T, Laurent L, Le Guillou X, Le Rhun M, Leblanc S, Levy P, Lievre A, Lorenzo D, Maire F, Marcel K, Masson E, Mauillon J, Morgant S, Moussata D, Muller N, Nambot S, Napoleon B, Olivier A, Pagenault M, Pelletier AL, Pennec O, Pinard F, Pioche M, Prost B, Queneherve L, Rebours V, Reboux N, Rekik S, Riachi G, Rohmer B, Roquelaure B, Rosa Hezode I, Rostain F, Saurin JC, Servais L, Stan-Iuga R, Subtil C, Tanneche J, Texier C, Thomassin L, Tougeron D, Vuitton L, Wallenhorst T, Wangerme M, Zanaldi H, Zerbib F, Bhaskar S, Kikuta K, Rao GV, Hamada S, Reddy DN, Masamune A, Chandak GR, Witt H, Férec C, Chen JM

Pancreatology. 2022 12 5;:

Reperfused human cadaver as a new simulation model for colonoscopy: a pilot study.

Rohr A, Perrenot C, Pitta A, Celerier I, Labrousse M, Renard Y, Cadiot G, Brugel M

Surg Endosc. 2022 11 28;:1-9

Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.

Lelièvre M, Triumbari EKA, Brixi H, Perrier M, Cadiot G, Deguelte S, Morland D

Endocrine. 2022 10 7;:

Orbital Metastasis: A Rare but Typical Location of Small Intestine Neuroendocrine Tumor on 18F-FDOPA PET/CT.

Morland D, Jallet L, Deguelte S, Cadiot G, Papathanassiou D

Clin Nucl Med. 2022 08 1;47(8):717-718

Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.

Meyer A, Fumery M, Peyrin-Biroulet L, Filippi J, Altwegg R, Bouhnik Y, Serrero M, Laharie D, Roblin X, Nachury M, Abitbol V, Cadiot G, Nancey S, Allez M, Gilletta C, Vuitton L, Savoye G, Nahon S, Bourrier A, Buisson A, Bouguen G, Bourreille A, Viennot S, Carbonnel F, Amiot A

Scand J Gastroenterol. 2022 07 12;:1-9

Aseptic splenic abscesses as the inaugural manifestation of Crohn's disease.

Favarel-Garrigues M, Cadiot G, Bermejo M, Boulagnon-Rombi C, Bani-Sadr F, Hentzien M

Clin Res Hepatol Gastroenterol. 2022 07 2;:101989

Concept of reintervention with thorough lymphadenectomy after suboptimal resection of small-intestine neuroendocrine neoplasms: A multicentre preliminary study.

Deguelte S, Hammoutene C, Poncet G, Brunaud L, Perrier M, Kianmanesh R, Cadiot G

J Neuroendocrinol. 2022 Mar 14;:e13117

Performances of 18F-FDOPA PET/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors.

Morland D, Jallerat P, Brixi H, Cadiot G, Papathanassiou D, Deguelte S

Clin Nucl Med. 2022 Jan 21;:

Efficacy of treatments for VIPoma: A GTE multicentric series.

Brugel M, Walter T, Goichot B, Smith D, Lepage C, Cao CD, Hautefeuille V, Rebours V, Cadiot G, de Mestier L,

Pancreatology. 2021 Aug 5;:

External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab.

Konecki C, Feliu C, Cazaubon Y, Giusti D, Tonye-Libyh M, Brixi H, Cadiot G, Biron A, Djerada Z

Pharmaceutics. 2021 Aug 3;13(8):

Oxaliplatin and 5-fluorouracil (FOLFOX) in advanced well differentiated digestive neuroendocrine tumors: a multicenter national retrospective study from the French Group of Endocrine Tumors (GTE).

Girot P, Baudin E, Senellart H, Bouarioua N, Hentic O, Guimbaud R, Walter T, Ferru A, Roquin G, Cadiot G, Pracht M, Girot JB, Malka D, Ducreux M, Bennouna J, Matysiak-Budnik T, Hadoux J, Touchefeu Y

Neuroendocrinology. 2021 Jul 26;:

Rectal neuroendocrine tumors: is it all on first sight?

de Mestier L, Cadiot G

Endoscopy. 2021 Jul;53(7):710-712

Diagnosis of postoperative recurrence of Crohn disease with MR-enterography: Value of diffusion-weighted imaging.

Djelouah M, Marical V, Kanagaratnam L, Kianmanesh R, Biron A, Cadiot G, Hoeffel C

Diagn Interv Imaging. 2021 Jun 18;:

Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the E

Hadoux J, Kanaan C, Durand A, Hescot S, Hautefeuille V, Cadiot G, Tauveron I, Laboureau S, Cao CD, Walter T, Petorin C, Blanchet O, Jannin A, Gu C, Faron M, Leteurtre E, Rousselet MC, Zakeyh JJ, Marchal A, Chatelain D, Beaulaton C, Hervieu V, Ducreux M, Scoazec JY, Baudin E

Eur J Cancer. 2021 Jun 2;152:100-115

Prognostic transcriptome classes of duodenopancreatic neuroendocrine tumors.

Diedisheim M, Dermine S, Jouinot A, Septier A, Gaujoux S, Dousset B, Cadiot G, Larger E, Bertherat J, Scharfmann R, Terris B, Coriat R, Assié G

Endocr Relat Cancer. 2021 Jun 1;:

Treatment outcomes of advanced digestive well-differentiated grade 3 NETs.

de Mestier L, Lamarca A, Hernando J, Zandee W, Alonso-Gordoa T, Perrier M, Walenkamp AME, Chakrabarty B, Landolfi S, Van Velthuysen MF, Kats-Ugurlu G, Carminoa A, Ronot M, Manoharan P, Garcia-Alvarez A, Brabander T, García Gómez-Muriel MI, Cadiot G, Couvelard A, Capdevilla J, Pavel ME, Cros J

Endocr Relat Cancer. 2021 Jun 1;:

Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumours.

De Rycke O, Walter T, Perrier M, Hentic O, Lombard-Bohas C, Coriat R, Cadiot G, Couvelard A, Ruszniewski P, Cros J, De Mestier L

Endocr Relat Cancer. 2021 May 1;:

Small Intestinal Neuroendocrine Neoplasm: Factors Associated with the Development of Local Tumor-Related Symptoms.

Deguelte S, Metoudi A, Rhaiem R, Hoeffel C, Brixi H, Cadiot G, Kianmanesh R

Neuroendocrinology. 2021 Apr 14;:

Clinical aspects of multiple endocrine neoplasia type 1.

Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P

Nat Rev Endocrinol. 2021 Feb 9;:

Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: a GTE study.

de Mestier L, Savagner F, Brixi H, Do Cao C, Dominguez-Tinajero S, Roquin G, Goichot B, Hentic O, Dubreuil O, Hautefeuille V, Walter T, Cadiot G

J Clin Endocrinol Metab. 2020 Dec 31;:

Defining and assessing the reproducibility of Crohn's disease endoscopic lesions: a Delphi-like method from the GETAID.

Buisson A, Filippi J, Amiot A, Cadiot G, Allez M, Marteau P, Bouhnik Y, Pineton de Chambrun G, Pelletier AL, Nancey S, Moussata D, Attar A, Blain A, Vuitton L, Vernier-Massouille G, Seksik P, Nachury M, Dupas JL, Laharie D, Peyrin-Biroulet L, Louis E, Mary JY

J Crohns Colitis. 2020 Dec 12;:

Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.

Perrier M, Delemer B, Deguelte S, Legros V, Brixi H, Kianmanesh R, Cadiot G

Pancreatology. 2020 Dec 7;:

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID.

Broussard D, Rivière P, Bonnet J, Fotsing G, Amiot A, Peyrin-Biroulet L, Rajca S, Buisson A, Gilleta C, Pelletier AL, Serrero M, Bouguen G, Altwegg R, Hebuterne X, Nancey S, Fumery M, Cadiot G, Nahon S, Rahier JF, Gornet JM, Vendrely V, Laharie D,

Aliment Pharmacol Ther. 2020 Nov 26;:

Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors.

Perrier M, Hentic O, Walter T, Cao CD, Cadiot G, de Mestier L,

Dig Liver Dis. 2020 Sep 19;:

Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study.

Lambin T, Amiot A, Stefanescu C, Gornet JM, Seksik P, Laharie D, Reenaers C, Bourreille A, Cadiot G, Carbonnel F, Dib N, Fumery M, Gilletta de St Joseph C, Filippi J, Viennot S, Plastaras L, Coffin B, Serrero M, Nahon S, Pineton de Chambrun G, Rahier JF, Roblin X, Boualit M, Bouguen G, Peyrin-Biroulet L, Pariente B,

Dig Liver Dis. 2020 Sep 19;:

Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors.

Deguelte S, Perrier M, Hammoutene C, Cadiot G, Kianmanesh R

J Clin Med. 2020 Jul 21;9(7):

Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR): A French Observational Study.

Delemer B, Nguyen-Tan-Hon T, Coriat R, Smith D, Schillo F, Raingeard I, Sobhani I, Etienne PL, Decoudier B, Bisot-Locard S, Santos A, Raverot G, Cadiot G

Adv Ther. 2020 Jul 18;:

[Isolated Crohn's disease of the vulva with rapid clinical response to infliximab and azathioprine].

Canard C, Diaz E, Gusdorf L, Loget J, Durlach A, Graesslin O, Cadiot G, Viguier M

Ann Dermatol Venereol. 2020 Jun 3;:

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study.

Amiot A, Filippi J, Abitbol V, Cadiot G, Laharie D, Serrero M, Altwegg R, Bouhnik Y, Peyrin-Biroulet L, Gilletta C, Roblin X, Pineton de Chambrun G, Vuitton L, Bourrier A, Nancey S, Gornet JM, Nahon S, Bouguen G, Viennot S, Pariente B, Fumery M,

Aliment. Pharmacol. Ther.. 2020 Apr 14;:

Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

de Mestier L, Lepage C, Baudin E, Coriat R, Courbon F, Couvelard A, Do Cao C, Frampas E, Gaujoux S, Gincul R, Goudet P, Lombard-Bohas C, Poncet G, Smith D, Ruszniewski P, Lecomte T, Bouché O, Walter T, Cadiot G,

Dig Liver Dis. 2020 Mar 28;:

[Rectal condyloma in high-grade dysplasia associated with high-risk HPV in a patient with refractory ulcerative colitis].

Beaudoux O, Cadiot G, Marchal A

Ann Pathol. 2020 Feb 8;:

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors.

Grenader T, Pavel ME, Ruszniewski PB, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Truong Thanh XM, Caplin ME,

Anticancer Drugs. 2020 Jan 21;:

Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.

Walter T, Lepage C, Coriat R, Barbier E, Cadiot G, Caroli-Bosc FX, Aparicio T, Bouhier-Leporrier K, Hentic-Dhome O, Gay F, Dupont-Gossart AC, Duluc M, Lepere C, Lecomte T, Smith D, Petorin C, Di-Fiore F, Ghiringhelli F, Legoux JL, Guimbaud R, Baudin E, Lombard-Bohas C, de Baère T,

Eur. J. Cancer. 2019 Oct 31;123:92-100

Severe attack of Henoch-Schönlein purpura with neurologic involvement during adalimumab treatment for Crohn's disease.

Condamina M, Diaz E, Jamart C, Loget J, Durlach A, Salmon JH, Cadiot G, Viguier M

J Crohns Colitis. 2019 Oct 7;:

Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).

Fine C, Roquin G, Terrebonne E, Lecomte T, Coriat R, Do Cao C, de Mestier L, Coffin E, Cadiot G, Nicolli P, Lepiliez V, Hautefeuille V, Ramos J, Girot P, Dominguez S, Céphise FV, Forestier J, Hervieu V, Pioche M, Walter T

United European Gastroenterol J. 2019 Oct;7(8):1102-1112

Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.

Minon M, Soriano C, Morland D, Walter T, Lepage C, Tabarin A, Deblock M, Rousset P, Barbe C, Hoeffel C, Cadiot G

Endocrine. 2019 Sep 28;:

One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.

Christou N, Mathonnet M, Gaujoux S, Cadiot G, Deguelte S, Kraimps JL, Lifante JC, Menegaux F, Mirallié E, Muscari F, Carnaille B, Pattou F, Sauvanet A, Goudet P

World J Surg. 2019 Aug 5;:

Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors.

de Mestier L, Armani M, Cros J, Hentic O, Rebours V, Cadiot G, Sauvanet A, Couvelard A, Lebtahi R, Ruszniewski P

Dig Liver Dis. 2019 Jul 23;:

Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors.

de Mestier L, Lorenzo D, Fine C, Cros J, Hentic O, Walter T, Panis Y, Couvelard A, Cadiot G, Ruszniewski P

Best Pract. Res. Clin. Endocrinol. Metab.. 2019 Jul 9;:101293

French and European Neuroendocrine Tumor Society consensus guidelines.

Cadiot G

Ann. Endocrinol. (Paris). 2019 Apr 11;:

Ustekinumab for skin reactions associated with anti-tumor necrosis factor-α agents in patients with inflammatory bowel diseases: A single-center retrospective study.

Ezzedine K, Visseaux L, Cadiot G, Brixi H, Bernard P, Reguiai Z

J. Dermatol.. 2019 Feb 28;:

Comparison of temozolomide-capecitabine to 5-fluorouracile-dacarbazine in 247 patients with advanced digestive neuroendocrine tumors using propensity score analyses.

de Mestier L, Walter T, Brixi H, Evrard C, Legoux JL, de Boissieu P, Hentic O, Cros J, Hammel P, Tougeron D, Lombard-Bohas C, Rebours V, Ruszniewski P, Cadiot G

Neuroendocrinology. 2019 Feb 13;:

Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).

Vinault S, Mariet AS, Le Bras M, Mirallié E, Cardot-Bauters C, Pattou F, Ruszniewski P, Sauvanet A, Chanson P, Baudin E, Elias D, Menegaux F, Gaujoux S, Borson-Chazot F, Lifante JC, Caron P, Carrère N, Tabarin A, Laurent C, Klein M, Brunaud L, Niccoli P, Sebag F, Cadiot G, Kianmanesh R, Luu M, Binquet C, Goudet P

Ann. Surg.. 2018 Dec 21;:

Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study.

Walter T, Lepage C, Coriat R, Barbier E, Cadiot G, Caroli Bosc FX, Aparicio T, Bouhier Leporrier K, Hentic Dhome O, Dupont-Gossart AC, Duluc M, Lepere C, Lecomte T, Smith D, Petorin C, Iwanicki Caron I, Ducreux MP, Lombard Bohas C, de Baere T

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii469

Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.

Dignass A, Akbar A, Baumgart DC, Bommelaer G, Bouguen G, Cadiot G, Gillessen A, Grimaud JC, Hart A, Hoque S, Makins R, Michiels C, Moreau J, Premchand P, Ramlow W, Schanz S, Subramanian S, von Tirpitz C, Bonaz B

Scand. J. Gastroenterol.. 2018 04;53(4):442-448

Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.

Baillet P, Cadiot G, Goutte M, Goutorbe F, Brixi H, Hoeffel C, Allimant C, Reymond M, Obritin-Guilhen H, Magnin B, Bommelaer G, Pereira B, Hordonneau C, Buisson A

World J. Gastroenterol.. 2018 Feb 7;24(5):641-650

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.

Walter T, Malka D, Hentic O, Lombard-Bohas C, Le Malicot K, Smith D, Ferru A, Assenat E, Cadiot G, Lievre A, Kurtz JE, Dahan L, Dubreuil O, Hautefeuille V, Lepere C, Gangloff A, Elhajbi F, Coriat R, Roquin G, Bouarioua N, Granger V, Scoazec JY, Lepage C

Dig Liver Dis. 2018 Feb;50(2):195-198

Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH).

Matysiak-Budnik T, Fabiani B, Hennequin C, Thieblemont C, Malamut G, Cadiot G, Bouché O, Ruskoné-Fourmestraux A

Dig Liver Dis. 2018 Feb;50(2):124-131

Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.

Lestra T, Kanagaratnam L, Mulé S, Janvier A, Brixi H, Cadiot G, Dohan A, Hoeffel C

Diagn Interv Imaging. 2018 Feb;99(2):73-81

Early Gastroenteropancreatic Neuroendocrine Tumors: Endoscopic Therapy and Surveillance.

Scherübl H, Cadiot G

Visc Med. 2017 Oct;33(5):332-338

Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.

de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P

Neuroendocrinology. 2017 Aug;:

Features of Autoimmune Pancreatitis Associated with Inflammatory Bowel Diseases.

Lorenzo D, Maire F, Stefanescu C, Gornet JM, Seksik P, Serrero M, Bournet B, Marteau P, Amiot A, Laharie D, Trang C, Coffin B, Bellaiche G, Cadiot G, Reenaers C, Racine A, Viennot S, Pauwels A, Bouguen G, Savoye G, Pelletier AL, Pineton de Chambrun G, Lahmek P, Nahon S, Abitbol V,

Clin. Gastroenterol. Hepatol.. 2017 Aug;:

The future: surgical advances in MEN1 therapeutic approaches and management strategies.

Sadowski SM, Cadiot G, Dansin E, Goudet P, Triponez F

Endocr. Relat. Cancer. 2017 Aug;:

Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).

Manfredi S, Walter T, Baudin E, Coriat R, Ruszniewski P, Lecomte T, Laurenty AP, Goichot B, Rohmer V, Roquin G, Cojocarasu OZ, Lombard-Bohas C, Lepage C, Morcet J, Cadiot G

Endocrine. 2017 Jun;:

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.

Walter T, Tougeron D, Baudin E, Le Malicot K, Lecomte T, Malka D, Hentic O, Manfredi S, Bonnet I, Guimbaud R, Coriat R, Lepère C, Desauw C, Thirot-Bidault A, Dahan L, Roquin G, Aparicio T, Legoux JL, Lombard-Bohas C, Scoazec JY, Lepage C, Cadiot G,

Eur. J. Cancer. 2017 May;79:158-165

Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).

Gérard JP, André T, Bibeau F, Conroy T, Legoux JL, Portier G, Bosset JF, Cadiot G, Bouché O, Bedenne L,

Dig Liver Dis. 2017 Apr;49(4):359-367

Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours.

Lepage C, Dahan L, Bouarioua N, Toumpanakis C, Legoux JL, Le Malicot K, Guimbaud R, Smith D, Tougeron D, Lievre A, Cadiot G, Di Fiore F, Bouhier-Leporrier K, Hentic O, Faroux R, Pavel M, Borbath I, Valle JW, Rinke A, Scoazec JY, Ducreux M, Walter T

Dig Liver Dis. 2017 Mar;:

Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.

Triponez F, Sadowski SM, Pattou F, Cardot-Bauters C, Mirallié E, Le Bras M, Sebag F, Niccoli P, Deguelte S, Cadiot G, Poncet G, Lifante JC, Borson-Chazot F, Chaffanjon P, Chabre O, Menegaux F, Baudin E, Ruszniewski P, Du Boullay H, Goudet P

Ann. Surg.. 2017 Mar;:

Chemotherapy in Well-Differentiated Pancreatic Neuroendocrine Tumours with Ki-67 ≥10%: Is there a More Effective Antitumor Regimen A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE).

Roquin G, Baudin E, Lombard-Bohas C, Cadiot G, Dominguez S, Guimbaud R, Niccoli P, Legoux JL, Mitry E, Rohmer V, Ruszniewski P, Walter T, Ducreux M, Couvelard A, Scoazec JY, Ramond-Roquin A, Caroli-Bosc FX, Hentic O

Neuroendocrinology. 2017 Feb;:

Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Metz DC, Cadiot G, Poitras P, Ito T, Jensen RT

Int J Endocr Oncol. 2017 ;4(4):167-185

Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.

de Mestier L, Pasmant E, Fleury C, Brixi H, Sohier P, Féron T, Diebold MD, Clauser E, Cadiot G,

Dig Liver Dis. 2017 Jan;49(1):98-102

Impact of Liver and Whole-Body Diffusion-Weighted MRI for Neuroendocrine Tumors on Patient Management: A Pilot Study.

Moryoussef F, de Mestier L, Belkebir M, Deguelte-Lardière S, Brixi H, Kianmanesh R, Hoeffel C, Cadiot G

Neuroendocrinology. 2017 ;104(3):264-272

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

Boschetti G, Nancey S, Daniel F, Pariente B, Lerebours E, Duclos B, Bourreille A, Cadiot G, Fumery M, Moreau J, Marteau P, Bouhnik Y, Louis E, Flourié B,

Inflamm. Bowel Dis.. 2016 Dec;22(12):2924-2932

Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's Disease.

Marteau P, Laharie D, Colombel JF, Martin L, Coevoet H, Allez M, Cadiot G, Bourreille A, Carbonnel F, Bouhnik Y, Coffin B, Duclos B, Dupas JL, Moreau J, Louis E, Mary JY,

J Crohns Colitis. 2016 Sep;10(9):1001-5

[Digestive neuroendocrine tumors].

de Mestier L, Deguelte-Lardière S, Brixi H, Kianmanesh R, Cadiot G

Rev Med Interne. 2016 Aug;37(8):551-60

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.

Dignass A, Akbar A, Hart A, Subramanian S, Bommelaer G, Baumgart DC, Grimaud JC, Cadiot G, Makins R, Hoque S, Bouguen G, Bonaz B

J Crohns Colitis. 2016 Jul;10(7):812-20

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study.

Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Gomez-Panzani E, Ruszniewski P,

Endocr. Relat. Cancer. 2016 Mar;23(3):191-9

Development and validation of the Nancy histological index for UC.

Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Cadiot G, Diebold MD, Danese S, Reinisch W, Schreiber S, Travis S, Peyrin-Biroulet L

Gut. 2015 Oct 13. pii: gutjnl-2015-310187

Toward Preoperative Classification of Lymph-Node Metastases in Patients with Small Intestine Neuroendocrine Tumours in the Era of Intestinal-Sparing Surgery.

Lardiere-Deguelte S, de Mestier L, Appere F, Vullierme MP, Zappa M, Hoeffel C, Noaves M, Brixi H, Hentic O, Ruszniewski P, Cadiot G, Panis Y, Kianmanesh R

Neuroendocrinology. 2015 Oct 8.

Menetrier's disease: Long-term remission with lanreotide.

Heurgue-Berlot A, Feron T, Jazeron JF, Hoeffel C, Diebold MD, Cadiot G

Clin Res Hepatol Gastroenterol. 2015 Sep 14. pii: S2210-7401(15)00203-X

Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.

de Mestier L, Gaujoux S, Cros J, Hentic O, Vullierme MP, Couvelard A, Cadiot G, Sauvanet A, Ruszniewski P, Richard S, Hammel P

Ann Surg. 2015 Aug;262(2):384-8

Gastric carcinoids escaping the currently available classification.

de Mestier L, Diebold MD, Devulder F, Picot R, Cadiot G

Scand J Gastroenterol. 2015 May;50(5):621-2

Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study.

de Mestier L, Hentic O, Cros J, Walter T, Roquin G, Brixi H, Lombard-Bohas C, Hammel P, Diebold MD, Couvelard A, Ruszniewski P, Cadiot G

Ann Intern Med. 2015 May 19;162(10):682-9

MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'etude des Tumeurs Endocrines.

Goudet P, Dalac A, Le Bras M, Cardot-Bauters C, Niccoli P, Levy-Bohbot N, du Boullay H, Bertagna X, Ruszniewski P, Borson-Chazot F, Verges B, Sadoul JL, Menegaux F, Tabarin A, Kuhn JM, d'Anella P, Chabre O, Christin-Maitre S, Cadiot G, Binquet C, Delemer B

J Clin Endocrinol Metab. 2015 Apr;100(4):1568-77

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.

Scialom S, Malamut G, Meresse B, Guegan N, Brousse N, Verkarre V, Derrieux C, Macintyre E, Seksik P, Savoye G, Cadiot G, Vuitton L, Marthey L, Carbonnel F, Cerf-Bensussan N, Cellier C

PLoS ONE. 2015 ;10(6):e0125024

Sunitinib achieved fast and sustained control of VIPoma symptoms.

de Mestier L, Walter T, Brixi H, Lombard-Bohas C, Cadiot G

Eur. J. Endocrinol.. 2015 Jan;172(1):K1-3

Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.

de Mestier L, Lardière-Deguelte S, Brixi H, O'Toole D, Ruszniewski P, Cadiot G, Kianmanesh R

Neuroendocrinology. 2015 ;101(2):105-11

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial.

Mitry E, Walter T, Baudin E, Kurtz JE, Ruszniewski P, Dominguez-Tinajero S, Bengrine-Lefevre L, Cadiot G, Dromain C, Farace F, Rougier P, Ducreux M

Eur. J. Cancer. 2014 Dec;50(18):3107-15

Olmesartan-associated enteropathy: results of a national survey.

Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F, Mesnard B, Chayvialle JA, Savoye G, Druez A, Parlier D, Abitbol V, Gompel M, Eoche M, Poncin E, Bobichon R, Colardelle P, Wils P, Salloum H, Peschard S, Zerbib F, Meresse B, Cerf-Bensussan N, Malamut G, Carbonnel F

Aliment Pharmacol Ther. 2014 Nov;40(9):1103-9

Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study.

Svrcek M, Piton G, Cosnes J, Beaugerie L, Vermeire S, Geboes K, Lemoine A, Cervera P, El-Murr N, Dumont S, Scriva A, Lascols O, Ardizzone S, Fociani P, Savoye G, Le Pessot F, Novacek G, Wrba F, Colombel JF, Leteurtre E, Bouhnik Y, Cazals-Hatem D, Cadiot G, Diebold MD, Rahier JF, Delos M, Flejou JF, Carbonnel F

Inflamm Bowel Dis. 2014 Sep;20(9):1584-92

Therapy of rectal carcinoids of 11 to 19 mm: a matter of debate.

Scherubl H, de Mestier L, Cadiot G

Gastrointest Endosc. 2014 Sep;80(3):532-3

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.

Seirafi M, de Vroey B, Amiot A, Seksik P, Roblin X, Allez M, Peyrin-Biroulet L, Marteau P, Cadiot G, Laharie D, Boureille A, De Vos M, Savoye G, Rahier JF, Carbonnel F, Bonaz B, Colombel JF, Bouhnik Y

Aliment Pharmacol Ther. 2014 Aug;40(4):363-73

Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Caplin ME, Pavel M, Cwikla JB, Phan AT, Raderer M, Sedlackova E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P

N Engl J Med. 2014 Jul 17;371(3):224-33

Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.

de Mestier L, Dromain C, d'Assignies G, Scoazec JY, Lassau N, Lebtahi R, Brixi H, Mitry E, Guimbaud R, Courbon F, d'Herbomez M, Cadiot G

Endocr Relat Cancer. 2014 Apr 28;21(3):R105-20

[Malignant insulinoma: recommendations for workup and treatment].

Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C

Presse Med. 2014 Jun;43(6 Pt 1):645-59

Factors related to bowel cleansing failure before colonoscopy: Results of the PACOME study.

Hautefeuille G, Lapuelle J, Chaussade S, Ponchon T, Molard BR, Coulom P, Laugier R, Henri F, Cadiot G

United European Gastroenterol J. 2014 Feb;2(1):22-9

Malignant insulinoma: recommendations for characterisation and treatment.

Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C

Ann Endocrinol (Paris). 2013 Dec;74(5-6):523-33

Updating the management of patients with rectal neuroendocrine tumors.

de Mestier L, Brixi H, Gincul R, Ponchon T, Cadiot G

Endoscopy. 2013 Dec;45(12):1039-46

Saccharomyces boulardii does not prevent relapse of Crohn's disease.

Bourreille A, Cadiot G, Le Dreau G, Laharie D, Beaugerie L, Dupas JL, Marteau P, Rampal P, Moyse D, Saleh A, Le Guern ME, Galmiche JP

Clin Gastroenterol Hepatol. 2013 Aug;11(8):982-7

Prospective evaluation of magnetic resonance enterography for the detection of mesenteric small bowel tumours.

Amzallag-Bellenger E, Soyer P, Barbe C, Diebold MD, Cadiot G, Hoeffel C

Eur Radiol. 2013 Jul;23(7):1901-10

Gastroscopy-associated transmission of extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa.

Bajolet O, Ciocan D, Vallet C, de Champs C, Vernet-Garnier V, Guillard T, Brasme L, Thiefin G, Cadiot G, Bureau-Chalot F

J Hosp Infect. 2013 Apr;83(4):341-3

International practice patterns and resource utilization in the treatment of neuroendocrine tumors.

Casciano R, Wang X, Stern L, Parikh R, Chulikavit M, Willet J, Liu Z, Strosberg J, Cadiot G, Riechelmann R

Pancreas. 2013 Mar;42(2):339-47

Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.

Palazzo M, Lombard-Bohas C, Cadiot G, Matysiak-Budnik T, Rebours V, Vullierme MP, Couvelard A, Hentic O, Ruszniewski P

Eur J Gastroenterol Hepatol. 2013 Feb;25(2):232-8

Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

Ito T, Cadiot G, Jensen RT

World J Gastroenterol. 2012 Oct 21;18(39):5495-503

Effectiveness of MR enterography for the assessment of small-bowel diseases beyond Crohn disease.

Amzallag-Bellenger E, Oudjit A, Ruiz A, Cadiot G, Soyer PA, Hoeffel CC

Radiographics. 2012 Sep-Oct;32(5):1423-44

Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.

Barbe C, Murat A, Dupas B, Ruszniewski P, Tabarin A, Vullierme MP, Penfornis A, Rohmer V, Baudin E, Le Rhun M, Gaye D, Marcus C, Cadiot G

Dig Liver Dis. 2012 Mar;44(3):228-34

New treatment strategies in advanced neuroendocrine tumours.

Walter T, Brixi-Benmansour H, Lombard-Bohas C, Cadiot G

Dig Liver Dis. 2012 Feb;44(2):95-105

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.

Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R

Neuroendocrinology. 2012;95(2):98-119

Phase II study of first-line FOLFIRI for progressive metastatic well-differentiated pancreatic endocrine carcinoma.

Brixi-Benmansour H, Jouve JL, Mitry E, Bonnetain F, Landi B, Hentic O, Bedenne L, Cadiot G

Dig Liver Dis. 2011 Nov;43(11):912-6

Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study.

Le Roux C, Lombard-Bohas C, Delmas C, Dominguez-Tinajero S, Ruszniewski P, Samalin E, Raoul JL, Renard P, Baudin E, Robaskiewicz M, Mitry E, Cadiot G

Dig Liver Dis. 2011 Oct;43(10):828-33

Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.

Cadiot G, Delaage PH, Fabry C, Soufflet C, Barthelemy P

Dig Liver Dis. 2011 Oct;43(10):784-7

Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.

Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Menegaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, Cadiot G, Beckers A, Guilhem I, Chabre O, Caron P, Du Boullay H, Verges B, Cardot-Bauters C

Eur J Endocrinol. 2011 Jul;165(1):97-105

Management of early gastrointestinal neuroendocrine neoplasms.

Scherubl H, Jensen RT, Cadiot G, Stolzel U, Kloppel G

World J Gastrointest Endosc. 2011 Jul 16;3(7):133-9.

Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study.

Vezzosi D, Walter T, Laplanche A, Raoul JL, Dromain C, Ruszniewski P, d'Herbomez M, Guigay J, Mitry E, Cadiot G, Leboulleux S, Lombard-Bohas C, Borson-Chazot F, Ducreux M, Baudin E

Int J Biol Markers. 2011 Apr-Jun;26(2):94-101

Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management.

Scherubl H, Jensen RT, Cadiot G, Stolzel U, Kloppel G

World J Gastrointest Endosc. 2010 Oct 16;2(10):325-34.

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

Scherubl H, Cadiot G, Jensen RT, Rosch T, Stolzel U, Kloppel G

Endoscopy. 2010 Aug;42(8):664-71

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.

Yao JC, Lombard-Bohas C, Baudin E, Kvols LK, Rougier P, Ruszniewski P, Hoosen S, St Peter J, Haas T, Lebwohl D, Van Cutsem E, Kulke MH, Hobday TJ, O'Dorisio TM, Shah MH, Cadiot G, Luppi G, Posey JA, Wiedenmann B

J Clin Oncol. 2010 Jan 1;28(1):69-76

Detection of hepatic metastases from carcinoid tumor: prospective evaluation of contrast-enhanced ultrasonography.

Hoeffel C, Job L, Ladam-Marcus V, Vitry F, Cadiot G, Marcus C

Dig Dis Sci. 2009 Sep;54(9):2040-6

Overlap syndrome triggered by acute viral hepatitis A.

Heurgue A, Bernard-Chabert B, Picot R, Cadiot G, Thiefin G

Eur J Gastroenterol Hepatol. 2009 Jun;21(6):708-9.

Increased risk of colonic neoplasia in patients with sporadic duodenal adenoma.

Lagarde S, Dauphin M, Delmas C, Vitry F, Bouche O, Thiefin G, Diebold MD, Cadiot G

Gastroenterol Clin Biol. 2009 May;33(5):441-5

Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France.

Lombard-Bohas C, Mitry E, O'Toole D, Louvet C, Pillon D, Cadiot G, Borson-Chazot F, Aparicio T, Ducreux M, Lecomte T, Etienne PL, Cacheux W, Legoux JL, Seitz JF, Ruszniewski P, Chayvialle JA, Rougier P

Neuroendocrinology. 2009;89(2):217-22

Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study.

Piton G, Cosnes J, Monnet E, Beaugerie L, Seksik P, Savoye G, Cadiot G, Flourie B, Capelle P, Marteau P, Lemann M, Colombel JF, Khouri E, Bonaz B, Carbonnel F

Am J Gastroenterol. 2008 Jul;103(7):1730-6

[Duodenal perforation during a secretin test]

Scaglia E, Brixi-Benmansour H, Lubrano D, Devulder F, Thiefin G, Cadiot G

Gastroenterol Clin Biol. 2008 Apr;32(4):375-7

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Boureille A, Duclos B, Seksik P, Mary JY, Colombel JF

Gut. 2007 Oct;56(10):1404-9

[A Multiple endocrine neoplasia type-1 observatory in a French-speaking area. A tool from the Endocrine Tumor study Group (GTE)]

Goudet P, Bonithon C, Costa A, Cadiot G, Baudin E, Murat A, Delemer B, Tabarin A, Lecomte P, Calender A

Ann Endocrinol (Paris). 2007 Jun;68(2-3):154-9

[Case report: pancreatic endocrine tumor]

Cadiot G

Gastroenterol Clin Biol. 2007 Feb;31(2):240-4.

Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease.

Heurgue A, Vitry F, Diebold MD, Yaziji N, Bernard-Chabert B, Pennaforte JL, Picot R, Louvet H, Fremond L, Geoffroy P, Schmit JL, Cadiot G, Thiefin G

Gastroenterol Clin Biol. 2007 Jan;31(1):17-25.

Is there any relationship between pernicious anemia and iron deficiency?

Lagarde S, Jovenin N, Diebold MD, Jaussaud R, Cahn V, Bertin E, Jolly D, Thiefin G, Cadiot G

Gastroenterol Clin Biol. 2006 Nov;30(11):1245-9.

[What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?].

Legoux JL, Bedenne L, Seitz JF, Pezet D, Rougier P, Bouche O, Barbare JC, Andre T, Malka D, Cadiot G, Ruskone-Foumestraux A, Landi B, Peiffert D, Ducreux M, Louvet C, Dorval E

Gastroenterol Clin Biol. 2006 Oct;30(10):1191-5.

Digestive calcitonin-secreting tumors of the foregut: comparison with non-calcitonin-secreting tumors.

Wuilmet L, Jovenin N, Larbre H, Levy-Bohbot N, Diebold MD, Jolly D, Delemer B, Thiefin G, Cadiot G

Eur J Gastroenterol Hepatol. 2006 Sep;18(9):951-5.

Digestive endocrine tumors.

Cadiot G, Baudin E, Partensky C, Ruszniewski P

Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S91-2S97.

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

Marteau P, Lemann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soule JC, Bourreille A, Metman E, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Abitbol V, Blum-Sperisen S, Mary JY

Gut. 2006 Jun;55(6):842-7

Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE.

Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A, Proye CA

World J Surg. 2006 May;30(5):654-62; discussion 663-4.

Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.

Lemann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF

Gastroenterology. 2006 Apr;130(4):1054-61.

[Flushing revealing the recurrence of a rectal gastrointestinal stromal tumour. Efficacy of imatinib].

Bouche O, Lagarde S, Guillou PJ, Ramaholimihaso F, Lubrano D, Diebold MD, Delattre JF, Nguyen TD, Cadiot G, Thiefin G

Gastroenterol Clin Biol. 2006 Apr;30(4):636-7.

Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.

Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A, Proye CA

Ann Surg. 2006 Feb;243(2):265-72.

Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.

Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin Hdu B, Chabre O, Jovenin N, Cadiot G

Am J Gastroenterol. 2006 Feb;101(2):266-73.

[Increasing incidence of esophageal adenocarcinoma: a new challenge].

Cadiot G

Gastroenterol Clin Biol. 2005 Dec;29(12):1253-7.

[Metastasis of pancreatic cancer in an old cholecystectomy scar].

Moncoucy X, Bouche O, Delattre JF, Diebold MD, Cadiot G, Thiefin G

Gastroenterol Clin Biol. 2005 Nov;29(11):1182-3.

Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo.

Palascak-Juif V, Bouvier AM, Cosnes J, Flourie B, Bouche O, Cadiot G, Lemann M, Bonaz B, Denet C, Marteau P, Gambiez L, Beaugerie L, Faivre J, Carbonnel F

Inflamm Bowel Dis. 2005 Sep;11(9):828-32.